Consolidated Statements of Cash Flows (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net loss	$ (26,599,576)	$ (17,489,971)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation expense	5,653,451	3,314,197
Depreciation and amortization	987,698	832,920
Changes in fair value of derivative liability	(23,175)	(68,556)
Change in acquisition-related contingent consideration	400,000	0
Bad debt recovery	(2,020)	(7,178)
Deferred income taxes	94,796	447,568
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(944,297)	(190,150)
Accounts receivable	(602,132)	359,163
Inventory	(762,788)	1,081,060
Unearned revenues	1,013,946	(1,106,299)
Other assets	(106,909)	(25,805)
Accounts payable, accrued expenses and other liabilities	(1,615,234)	(272,718)
Net cash used in operating activities	(22,506,240)	(13,125,769)
Cash flows from investing activities:
Net cash received in acquisitions	50,894	0
Purchase of marketable securities	(919,829)	0
Acquisition of property and equipment	(2,439,266)	(268,535)
Net cash used in investing activities	(3,308,201)	(268,535)
Cash flows from financing activities:
Proceeds from exercise of options	230,183	0
Proceeds from exercise of warrants	1,373,925	105,881
Net proceeds from issuance of common stock	10,149,439	14,248,148
Repayment of mortgage loan	(105,450)	(93,070)
Proceeds from notes payable	1,340,981	221,218
Repayment of notes payable	(443,325)	(96,608)
Payment for warrant inducement	0	(6,239)
Net cash provided by financing activities	12,545,753	14,379,330
Net (decrease) increase in cash and cash equivalents	(13,268,688)	985,026
Cash and cash equivalents at beginning of period	46,133,759	13,737,452
Cash and cash equivalents at beginning of period	32,865,071	14,722,478
Cash paid during the period for:
Interest	196,200	126,000
Taxes	0	0
Common stock and contingent consideration issued in merger	$ 35,252,451	$ 0